Public Citizen Reignites Calls For FDA To Ban Certain IV Solutions

January 12, 2018
In response to the European Medicines Agency's Friday (Jan. 12) recommendation that all hydroxyethyl starch (HES) IV solutions be removed from the market in Europe, Public Citizen is reigniting its calls for FDA to follow suit, saying a complete ban on the solutions is the only way to “prevent further unnecessary patient deaths and injuries.” The group also points to its February 2017 petition to FDA calling for a ban of HES solutions, saying that FDA has “failed to respond...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.